UnitedHealth Group has had a difficult year marked by a dramatic stock drop, leadership shake-up and mounting regulatory scrutiny. Experts point to its aggressive Medicare Advantage strategy and a rapidly evolving healthcare landscape as key drivers of its challenges.
The post Analysis: The No Good, Very Bad Year for UnitedHealth appeared first on MedCity News.
